tirzepatide color pink ODT | Oral GLP-1 Weight Loss Semaglutide vs Tirzepatide in Grapevine

Description

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes and obesity, have evolved into multi-organ potential therapeuti...

Lemon balm is known for its calming properties

Retatrutide is a single molecule that acts as a triple agonist for GLP-1, GIP, and glucagon receptors, designed to improve metabolic health beyond simple caloric restriction

The first phase 3 retatrutide trial, TRIUMPH-4, top-line data announced today Retatrutide, a triple GLP-1,GIP, glucagon agonist studied in patients with obesity and osteoarthritis 28.7% weight loss at 68 weeks Reduced key cardiometabolic risk markers non-HDL cholesterol, triglycerides, and hsCRP Highest dose lowered systolic BP by 14 mmHg Reduced WOMAC pain scores by up to an average of 4.5 points (75.8%) and significantly improved measures of physical function GI side effects most common adverse event We now await 7 additional phase 3 trials in other obesity related comorbidities